Ipratropium bromide versus long‐acting beta‐2 agonists for stable chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with long acting beta‐2 agonists (LABAs) and anticholinergic bronchodilator medications, both of which are recomm...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Appleton, Sarah, Jones, Terry, Poole, Phillippa, Lasserson, Toby J, Adams, Robert, Smith, Brian J, Muhammed, Julia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2006
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7200053/
https://ncbi.nlm.nih.gov/pubmed/16856113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006101
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller